Butallylonal: Difference between revisions

Latest revision as of 12:07, 15 February 2025

Butallylonal[edit]

Butallylonal is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which made it useful in the treatment of insomnia and as a pre-anesthetic agent. Like other barbiturates, Butallylonal works by depressing the central nervous system.

Chemical Properties[edit]

Butallylonal is chemically classified as a barbiturate, which is a class of drugs derived from barbituric acid. The chemical structure of Butallylonal includes a pyrimidine ring, which is characteristic of barbiturates. The presence of various substituents on the ring structure influences its pharmacological activity.

Pharmacology[edit]

Butallylonal acts as a central nervous system depressant. It enhances the activity of the gamma-aminobutyric acid (GABA) neurotransmitter by binding to the GABA_A receptor, which increases the duration of chloride ion channel opening, leading to hyperpolarization of the neuron and decreased neuronal activity.

Mechanism of Action[edit]

The primary mechanism of action of Butallylonal is through potentiation of GABAergic transmission. By binding to the GABA_A receptor, Butallylonal increases the inhibitory effects of GABA, leading to sedation and hypnosis.

Clinical Uses[edit]

Historically, Butallylonal was used as a sedative and hypnotic for the treatment of insomnia and as a pre-anesthetic medication. However, due to the development of safer alternatives, its use has declined.

Side Effects[edit]

Common side effects of Butallylonal include drowsiness, dizziness, and ataxia. In higher doses, it can cause respiratory depression, hypotension, and coma.

History[edit]

Butallylonal was first synthesized in the early 20th century as part of the development of barbiturate drugs. It was used clinically for several decades before being largely replaced by benzodiazepines and other non-barbiturate sedatives.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-'''Butallylonal''' is a [[sedative]] drug that was first synthesized in the 1920s. It is a [[barbiturate]] derivative and has [[anesthetic]], [[anticonvulsant]], [[sedative]], and [[hypnotic]] properties. Butallylonal is not commonly used in modern medicine, but it was historically used for the induction of [[anesthesia]] in surgical procedures.
+== Butallylonal ==
-== History ==
+[[File:Butallylonal_structure.svg|thumb|right|Chemical structure of Butallylonal]]
+'''Butallylonal''' is a [[barbiturate]] derivative that was developed in the early 20th century. It is known for its [[sedative]] and [[hypnotic]] properties, which made it useful in the treatment of [[insomnia]] and as a [[pre-anesthetic]] agent. Like other barbiturates, Butallylonal works by depressing the [[central nervous system]].
+== Chemical Properties ==
-Butallylonal was first synthesized in the 1920s as part of a series of barbiturate derivatives. It was used in the mid-20th century as an anesthetic for surgical procedures. However, its use has declined due to the development of safer and more effective anesthetics.
+Butallylonal is chemically classified as a [[barbiturate]], which is a class of drugs derived from [[barbituric acid]]. The chemical structure of Butallylonal includes a [[pyrimidine]] ring, which is characteristic of barbiturates. The presence of various substituents on the ring structure influences its pharmacological activity.
 == Pharmacology ==
-As a barbiturate, butallylonal acts as a [[GABA]] agonist, increasing the activity of this inhibitory neurotransmitter in the brain. This results in a decrease in nerve activity, leading to sedation and a decrease in anxiety. In higher doses, butallylonal can induce anesthesia.
+Butallylonal acts as a [[central nervous system]] depressant. It enhances the activity of the [[gamma-aminobutyric acid]] (GABA) neurotransmitter by binding to the [[GABA_A receptor]], which increases the duration of [[chloride ion]] channel opening, leading to hyperpolarization of the neuron and decreased neuronal activity.
-== Medical uses ==
+=== Mechanism of Action ===
-Historically, butallylonal was used as an anesthetic for surgical procedures. It was also used to treat [[insomnia]] and [[anxiety]] disorders. However, it is not commonly used in modern medicine due to the risk of [[addiction]] and the development of safer alternatives.
+The primary mechanism of action of Butallylonal is through potentiation of GABAergic transmission. By binding to the GABA_A receptor, Butallylonal increases the inhibitory effects of GABA, leading to sedation and hypnosis.
-== Side effects ==
+=== Clinical Uses ===
-The side effects of butallylonal are similar to those of other barbiturates. They include drowsiness, dizziness, and confusion. In higher doses, butallylonal can cause respiratory depression, coma, and death.
+Historically, Butallylonal was used as a [[sedative]] and [[hypnotic]] for the treatment of [[insomnia]] and as a [[pre-anesthetic]] medication. However, due to the development of safer alternatives, its use has declined.
-== See also ==
+== Side Effects ==
+Common side effects of Butallylonal include [[drowsiness]], [[dizziness]], and [[ataxia]]. In higher doses, it can cause [[respiratory depression]], [[hypotension]], and [[coma]].
+== History ==
+Butallylonal was first synthesized in the early 20th century as part of the development of barbiturate drugs. It was used clinically for several decades before being largely replaced by [[benzodiazepines]] and other [[non-barbiturate]] sedatives.
+== Related Pages ==
 * [[Barbiturate]]
-* [[Anesthesia]]
 * [[Sedative]]
+* [[Hypnotic]]
+* [[GABA_A receptor]]
+* [[Insomnia]]
 [[Category:Barbiturates]]
-[[Category:Anesthetics]]
 [[Category:Sedatives]]
 [[Category:Hypnotics]]
-{{stub}}
-{{No image}}